当前位置: X-MOL 学术Hepatology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
PDLIM1 inhibits tumor metastasis through activating Hippo signaling in hepatocellular carcinoma
Hepatology ( IF 13.5 ) Pub Date : 2020-01-21 , DOI: 10.1002/hep.30930
Zhao Huang 1 , Jian-Kang Zhou 1 , Kui Wang 1 , Haining Chen 2 , Siyuan Qin 1 , Jiayang Liu 1 , Maochao Luo 1 , Yan Chen 1 , Jingwen Jiang 1 , Li Zhou 1 , Lei Zhu 1 , Juan He 1 , Jiao Li 1 , Wenchen Pu 1 , Yanqiu Gong 1 , Jianbo Li 3 , Qin Ye 4 , Dandan Dong 5 , Hongbo Hu 1 , Zongguang Zhou 2 , Lunzhi Dai 1 , Canhua Huang 1 , Xiawei Wei 6 , Yong Peng 1
Affiliation  

Tumor metastasis is a major factor of high recurrence and mortality in hepatocellular carcinoma (HCC), but its underlying mechanism remains elusive. We report that PDZ and LIM domain protein 1 (PDLIM1) is significantly down‐regulated in metastatic human HCC tissues, which predicts unfavorable prognosis, suggesting that PDLIM1 may play an important inhibitory role during HCC metastasis.

中文翻译:

PDLIM1通过激活Hippo信号抑制肝细胞癌的肿瘤转移

肿瘤转移是肝细胞癌(HCC)高复发率和死亡率的主要因素,但其潜在机制尚不清楚。我们报告说,PDZ 和 LIM 结构域蛋白 1(PDLIM1)在转移性人类 HCC 组织中显着下调,这预示着不良预后,表明 PDLIM1 可能在 HCC 转移过程中发挥重要的抑制作用。
更新日期:2020-01-21
down
wechat
bug